浩雲科技(300448.SZ):雷洪文減持67.95萬股 持股降至5%以下
格隆匯12月16日丨浩雲科技(300448.SZ)公佈,公司於2019年12月16日收到持股5%以上股東、董事、總經理雷洪文的《關於股份權益變動的告知函》及《簡式權益變動報告書》,獲悉其因個人資金使用安排,於2019年12月16日通過深圳證券交易所交易系統以大宗交易方式減持其持有的公司部分無限售流通股股份,減持67.95萬股,佔總股本比例0.0981%。
此次減持後,雷洪文持股3433.03萬股,佔總股本比例4.9587%,佔剔除回購專用賬户股份後總股本比例4.9999%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.